In the dim-lit corridors of investment, many cast their eager gaze upon the shimmering ascent, hopeful that the year ahead-2026-will mirror previous triumphs. Yet beneath that veneer of optimism, a lesser-known indicator stirs-a spectral warning whispering from the shadows, repeating a refrain that history etched deep into its ledger.
An SEC filing, that most thrilling of bedtime reading material, revealed Tikvah had offloaded 400,000 PAYO shares during Q3 at an average price that would make a dragon hoard blush. The proceeds, $2.68 million, joined the fund’s coffers while leaving them with 1.29 million shares valued at $7.82 million. This reduced Payoneer’s presence in their portfolio to a mere 2.3% stake2-a position now dwarfed by titanic holdings like Alphabet and Amazon, which loom over Tikvah’s portfolio like colossi straddling the Strait of Gibraltar.
A filing, crisp as a new leaf, revealed Sand Grove’s purchase of 39,121 shares in CyberArk (CYBR 0.72%) by quarter’s end, valued at $18.9 million. The gesture, though modest against the vast forest of capital, hinted at a belief in the sap rising within this particular tree.
In what’s being called “the most romantic SEC filing since Elon tweeted about Dogecoin,” Sand Grove disclosed a shiny new 829,123-share position in STAAR Surgical (STAA 1.63%). Let’s pause to admire the math: $22.28 million invested in a company whose market cap could fit inside Jeff Bezos’s yacht closet. The filing, dated November 14, 2025, reads like a financial rom-com where the protagonist buys a timeshare in a struggling ophthalmology-themed amusement park.
Behold, the key edicts of this financial manifesto:
Park’s argument is as simple as it is devastating: Bitcoin’s soul has always been tied to volatility. When that volatile spirit wanes, so too does the allure of risk capital-those intrepid souls who rush in first, propelling prices upward, only to vanish as the next wave arrives. “We need two things,” he intoned, “a belief in Bitcoin’s future and a rise in volatility. And yet, why is this not happening today?” One might wonder if the market has forgotten the very chaos that once made Bitcoin a darling of the speculative elite.
They’re selling exposure to digital magic internet money through old-man investment vehicles. Brilliant! No wallets, no passwords – just good ol’ AMEX tickers. Who needs blockchain when you’ve got custodians? Revolutionary. [eye roll]
ADA, that eternal glutton for punishment, limps near $0.36-a 60% nose-dive from October’s glory days. Yet the top traders, those sly foxes in crypto fur coats, plot their comebacks like chessmasters, as if the market is a pawn shop of opportunities. And what of their positional ratio, 1.33? Oh, how pedestrian! It’s the financial equivalent of whispering “I’m not greedy” while clutching a briefcase full of gold doubloons. Accumulation phases, indeed. More like a slow-burn heist.
These two noble ETFs strive to grant the weary investor passage into the realms of emerging markets, yet they differ as one might contrast a peacock strutting in full plume with a sparrow observing from the hedgerow. This analysis seeks to elucidate the nuances of expenses, returns, risks, and the labyrinthine paths of trading, assisting investors in discerning which vessel may better suit their financial journey.
Suvretta Capital Management, a U.S.-based investment adviser, reported in a November 14 SEC filing that it increased its stake in Mineralys Therapeutics during the third quarter. The fund acquired 387,641 additional shares, bringing total holdings to 2.13 million shares worth $80.85 million as of September 30. The fund reported 93 total positions for the quarter. (A footnote: 93 positions is roughly the number of things a person might worry about if they were a fund manager and also a neurotic parrot.)